Skip to content

Restricted Cash at other companies

Omnicell logo
OmnicellOMCL
$51.7M+87.3%
Baxter International logo
Baxter InternationalBAX
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%
Free cash flow$546.0M

Valuation

See full
Market cap$41.7B-14.4%
Enterprise value$55.39B-15.4%
P/E36.6×+5.9×
P/S-0.4×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsCurrent.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's restricted cash?
Becton, Dickinson and Company (BDX) reported restricted cash of $202M in Q1 2026.
How has Becton, Dickinson and Company's restricted cash changed year-over-year?
Becton, Dickinson and Company's restricted cash increased by 152.5% year-over-year, from $80M to $202M.
What is the long-term trend for Becton, Dickinson and Company's restricted cash?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's restricted cash has grown at a 17.8% compound annual growth rate (CAGR), from $109M to $210M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.